1. Home
  2. CAPL vs AURA Comparison

CAPL vs AURA Comparison

Compare CAPL & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CrossAmerica Partners

CAPL

CrossAmerica Partners

HOLD

Current Price

$21.60

Market Cap

850.5M

Sector

Energy

ML Signal

HOLD

Logo Aura Biosciences Inc.

AURA

Aura Biosciences Inc.

HOLD

Current Price

$7.50

Market Cap

772.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAPL
AURA
Founded
1992
2007
Country
United States
United States
Employees
N/A
113
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
850.5M
772.3M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
CAPL
AURA
Price
$21.60
$7.50
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$20.00
AVG Volume (30 Days)
50.2K
772.3K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
9.96%
N/A
EPS Growth
96.15
N/A
EPS
0.26
N/A
Revenue
$1,869,806,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.80
N/A
P/E Ratio
$85.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.61
$4.73
52 Week High
$23.34
$9.54

Technical Indicators

Market Signals
Indicator
CAPL
AURA
Relative Strength Index (RSI) 44.76 48.84
Support Level $21.53 $5.94
Resistance Level $23.08 $7.68
Average True Range (ATR) 0.71 0.35
MACD -0.09 -0.08
Stochastic Oscillator 6.04 25.90

Price Performance

Historical Comparison
CAPL
AURA

About CAPL CrossAmerica Partners

CrossAmerica Partners LP is engaged in the wholesale distribution of motor fuel and the ownership and leasing of real estate used in the retail distribution of motor fuel. The company operates through two business segments namely Wholesale and Retail. The Wholesale segment is a key revenue driver and includes the wholesale distribution of motor fuel to lessee dealers, independent dealers, commission agents, DMS, Circle K, and through company-operated retail sites. The Retail segment includes the sale of convenience merchandise items, the retail sale of motor fuel at company-operated retail sites, and the retail sale of motor fuel at retail sites operated by commission agents.

About AURA Aura Biosciences Inc.

Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.

Share on Social Networks: